HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of the results of short-term rigid and semi-rigid cast immobilization for the treatment of grade 3 inversion injuries of the ankle.

Abstract
In this prospective, randomized study, short-term immobilization with semi-rigid (Soft Cast) and rigid (Scotchcast Plus) synthetic cast materials were compared for the functional treatment of acute grade 3 lateral ligament injuries of the ankle. Degree of ligament injury was assessed by clinical criteria. Duration of immobilization was 2 weeks for both groups and home physiotherapy was started thereafter. Fifty-seven patients completed the study and both materials were found to be equally effective in providing a stable ankle at the end of 6 weeks follow-up. Soft Cast group had better range of motion and could walk better at 2 weeks, but these differences diminished at 6 weeks. With the Soft Cast, patient satisfaction was higher, need for a support for walking was less and return to work was earlier. When combined with the reduced cost of application, Soft Cast is the material of choice for the initial short-term immobilization for the functional treatment of acute ankle ligament injuries.
AuthorsS Avci, U Sayli
JournalInjury (Injury) Vol. 29 Issue 8 Pg. 581-4 (Oct 1998) ISSN: 0020-1383 [Print] Netherlands
PMID10209587 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Topics
  • Adolescent
  • Adult
  • Ankle Injuries (rehabilitation, therapy)
  • Casts, Surgical
  • Combined Modality Therapy
  • Female
  • Fracture Fixation (methods)
  • Humans
  • Immobilization
  • Male
  • Middle Aged
  • Physical Therapy Modalities
  • Prospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: